Evaluating Fluid Responsiveness in ICU Patients Using VTI and Trendelenburg Positioning
Launched by LENOX HILL HOSPITAL · May 13, 2024
Trial Information
Current as of February 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better predict which critically ill patients in the ICU will benefit from receiving extra fluids. Sometimes, giving fluids can help, but it can also cause problems like too much fluid in the body. The researchers are looking at two methods: using something called velocity time integral (VTI), which helps measure blood flow, and placing patients in a position called Trendelenburg, where they lie back with their legs elevated. By doing this, they hope to identify patients who are more likely to respond positively to fluid therapy.
To participate in the trial, patients must be adults aged 18 or older who are in the medical or surgical ICU and need fluid treatment due to signs like low blood pressure, fast heart rate, or low urine output. However, patients who are pregnant, unable to safely lie in the Trendelenburg position, or have certain heart issues may not be eligible. If someone joins the study, they can expect to undergo evaluations that will help determine their response to fluids, contributing to better care for themselves and future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (≥ 18 years old) admitted to the medical or surgical ICU.
- • Patients who require fluid administration for suspicion of hypovolemia or indicated for volume expansion due to any one of the following: hypotension (systolic blood pressure \< 90 mm Hg or mean arterial pressure \< 65 mm Hg), tachycardia (heart rate \> 100 beats per min), blood lactate \> 2.0 mmol/L, skin mottling, oliguria (urine output \< 30 ml/hr), or requiring vasopressor/inotrope support.
- • Patients who are able to tolerate the Trendelenburg position.
- Exclusion Criteria:
- • Pregnancy.
- • Prisoners and institutionalized patients.
- • Patients who are not able to tolerate the Trendelenburg position. This includes patients with increased intra-cranial hypertension, intra-abdominal hypertension and gastric retention which places a risk for stomach fluid aspiration.
- • Unsatisfactory cardiac echogenicity (an inability to correctly align the Doppler beam to generate reliable VTI measurements at the left ventricular outflow tract \[LVOT\]).
Trial Officials
Matthew Kheir, MD
Principal Investigator
Lenox Hill Hospital- Northwell Health
About Lenox Hill Hospital
Lenox Hill Hospital is a prominent healthcare institution located in New York City, renowned for its commitment to delivering high-quality patient care and advancing medical research. As a sponsor of clinical trials, Lenox Hill Hospital leverages its state-of-the-art facilities and a diverse team of expert clinicians to explore innovative treatment options across various medical disciplines. The hospital is dedicated to enhancing patient outcomes through rigorous scientific inquiry, collaboration with leading researchers, and adherence to ethical standards in clinical research. With a focus on translational medicine, Lenox Hill Hospital strives to bridge the gap between laboratory discoveries and clinical application, ultimately contributing to the advancement of healthcare practices and improved patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0